FTM

First Turn Management Portfolio holdings

AUM $666M
1-Year Est. Return 86.8%
This Quarter Est. Return
1 Year Est. Return
+86.8%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$666M
AUM Growth
+$130M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$35.8M
2
+$25.5M
3
+$24.8M
4
KYMR icon
Kymera Therapeutics
KYMR
+$15.7M
5
ROIV icon
Roivant Sciences
ROIV
+$14.5M

Top Sells

1
+$29.3M
2
+$17.6M
3
+$16.2M
4
TGTX icon
TG Therapeutics
TGTX
+$16.1M
5
GH icon
Guardant Health
GH
+$15.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
26
ADMA Biologics
ADMA
$4.69B
$11.9M 1.78%
808,673
-283,688
VERA icon
27
Vera Therapeutics
VERA
$2.64B
$10.3M 1.55%
354,529
+44,863
HROW icon
28
Harrow
HROW
$1.65B
$7.72M 1.16%
160,234
-68,527
MLTX icon
29
MoonLake Immunotherapeutics
MLTX
$946M
$1.88M 0.28%
+262,643
ALNY icon
30
Alnylam Pharmaceuticals
ALNY
$62.5B
– –
-17,879
BSX icon
31
Boston Scientific
BSX
$146B
– –
-138,834
GH icon
32
Guardant Health
GH
$13.8B
– –
-302,307
HQY icon
33
HealthEquity
HQY
$8.5B
– –
-80,880
ISRG icon
34
Intuitive Surgical
ISRG
$202B
– –
-32,305
KALV icon
35
KalVista Pharmaceuticals
KALV
$741M
– –
-214,138
PODD icon
36
Insulet
PODD
$21.6B
– –
-51,408
RDNT icon
37
RadNet
RDNT
$6.13B
– –
-197,759
SLNO icon
38
Soleno Therapeutics
SLNO
$2.72B
– –
-86,332
SPRY icon
39
ARS Pharmaceuticals
SPRY
$944M
– –
-455,953
TGTX icon
40
TG Therapeutics
TGTX
$5.02B
– –
-447,884
VRNA
41
DELISTED
Verona Pharma
VRNA
– –
-309,988
BBNX
42
Beta Bionics
BBNX
$1.34B
– –
-157,194
1
2